Phenotyping left ventricular systolic dysfunction in asymptomatic individuals for improved risk stratification
Open Access
- 12 September 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 24 (10) , 1363-1373
Abstract
Left ventricular systolic dysfunction (LSVD) is a heterogeneous condition with several factors influencing prognosis. Better phenotyping of asymptomatic individuals can inform preventative strategies. This study aims to explore the clinical phenotypes of LVSD in initially asymptomatic subjects and their association with clinical outcomes and cardiovascular abnormalities through multi-dimensional data clustering. Clustering analysis was performed on 60 clinically available variables from 1563 UK Biobank participants without pre-existing heart failure (HF) and with left ventricular ejection fraction (LVEF) < 50% on cardiovascular magnetic resonance (CMR) assessment. Risks of developing HF, other cardiovascular events, death, and a composite of major adverse cardiovascular events (MACE) associated with clusters were investigated. Cardiovascular imaging characteristics, not included in the clustering analysis, were also evaluated. Three distinct clusters were identified, differing considerably in lifestyle habits, cardiovascular risk factors, electrocardiographic parameters, and cardiometabolic profiles. A stepwise increase in risk profile was observed from Cluster 1 to Cluster 3, independent of traditional risk factors and LVEF. Compared with Cluster 1, the lowest risk subset, the risk of MACE ranged from 1.42 [95% confidence interval (CI): 1.03–1.96; P < 0.05] for Cluster 2 to 1.72 (95% CI: 1.36–2.35; P < 0.001) for Cluster 3. Cluster 3, the highest risk profile, had features of adverse cardiovascular imaging with the greatest LV re-modelling, myocardial dysfunction, and decrease in arterial compliance. Clustering of clinical variables identified three distinct risk profiles and clinical trajectories of LVSD amongst initially asymptomatic subjects. Improved characterization may facilitate tailored interventions based on the LVSD sub-type and improve clinical outcomes. Using clustering analysis of clinical data, we identified three distinct LVSD phenotypes amongst initially asymptomatic subjects (A, B). These phenotypes correlated with varying risks of adverse CV events (C) and were characterized by unique clinical features and CV imaging patterns (D). CV, cardiovascular; LVSD, left ventricular systolic dysfunction.Keywords
Funding Information
- London Medical Imaging and Artificial Intelligence Centre
- UK Research and Innovation (EP/P001009/1)
- National Institute for Health Research
- Biomedical Research Centre
- British Heart Foundation
- Academy of Medical Sciences
- mini-Centre for Doctoral Training
- Faculty of Science and Engineering
- Queen Mary University of London
This publication has 26 references indexed in Scilit:
- Phenomapping for Novel Classification of Heart Failure With Preserved Ejection FractionCirculation, 2015
- Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fractionEuropean Heart Journal - Cardiovascular Imaging, 2014
- Proximal Aortic Distensibility Is an Independent Predictor of All-Cause Mortality and Incident CV EventsJACC, 2014
- Prognosis of Individuals With Asymptomatic Left Ventricular Systolic Dysfunction in the Multi-Ethnic Study of Atherosclerosis (MESA)Circulation, 2012
- Sex/Gender Differences in Cardiovascular Disease PreventionCirculation, 2011
- Sex-Related Differences in Myocardial RemodelingJACC, 2010
- Resampling Method for Unsupervised Estimation of Cluster ValidityNeural Computation, 2001
- Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodelingJACC, 2000
- Relations of Left Ventricular Mass to Fat-Free and Adipose Body MassCirculation, 1998
- Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban populationThe Lancet, 1997